Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs LSCC✓SelectedUSD · LSCCGSK vs LSCC performance historyLatest closeAs of+0.52%11/13
Stock and ETF performance explorer

GSK vs LSCC

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+44.4%
LSCC return
+33.9%
Excess return
+10.4%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioLSCCExcessAlpha
1D+0.5%-5.5%+6.0%+0.8%
7D+1.1%+7.0%-5.8%+0.8%
30D+6.3%-2.3%+8.6%+6.3%
3M+1.8%-12.5%+14.3%+2.2%
6M+1.7%-10.6%+12.2%+1.2%
YTD+6.5%+52.7%-46.1%+1.6%
1Y+9.5%+74.0%-64.5%+3.4%
3Y+65.3%+104.8%-39.5%+52.3%
All+44.4%+33.9%+10.4%+31.2%

Cumulative growth

Daily Returns

Daily percentage return beside LSCC.

Daily Out/Under-Performance

Portfolio return minus LSCC return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × LSCC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded LSCC wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling